Sanofi is a global biopharmaceutical company dedicated to supporting people through their health challenges. With a presence in over 100 countries, Sanofi focuses on human health by preventing illness with vaccines and providing innovative treatments to fight pain and alleviate suffering. They are committed to standing by those who suffer from rare diseases and millions with long-term chronic conditions.

Sanofi's extensive portfolio includes a wide range of products and services. They have a strong emphasis on research and development, with a pipeline that spans multiple therapeutic areas such as immunology, neurology, oncology, rare blood disorders, rare diseases, and vaccines. Clinical studies and scientific collaboration play a vital role in driving their innovative solutions.

In addition to pharmaceuticals, Sanofi also offers consumer healthcare products and solutions, supporting patient and healthcare professional needs. They are dedicated to sustainability and social impact, focusing on environmental sustainability, diversity, equity, and inclusion. By completing the acquisition of Kiadis, a clinical-stage biopharmaceutical company, Sanofi reinforces its position in immuno-oncology.

This alignment with their strategy allows them to pursue best-in-class treatments in defined areas, ultimately empowering life and transforming scientific innovation into healthcare solutions worldwide